Cleveland-Cliffs (NYSE: CLF) insider transactions
In the twelve months to 10 November 2026, executives and directors of Cleveland-Cliffs reported 3 open-market sales of 3,414,308 shares ($42.2m) and 2 open-market purchases of 27,100 shares ($299,387), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 22 October 2026 | Camara Edilson | Director | Open-market purchase | +7,400 | $13.49 | 64,717 | Form 4 |
| 1 October 2026 | Bloom Ron A. | Director | Grant or award | +3,487 | $11.47 | 130,841 | Form 4 |
| 1 October 2026 | Cronin Jane M. | Director | Grant or award | +3,487 | $11.47 | 81,843 | Form 4 |
| 1 July 2026 | Bloom Ron A. | Director | Grant or award | +4,246 | $9.42 | 127,354 | Form 4 |
| 1 July 2026 | Cronin Jane M. | Director | Grant or award | +4,246 | $9.42 | 78,356 | Form 4 |
| 5 June 2026 | Goncalves Celso L Jr | EVP, CFO | Open-market sale | −214,308 | $13.41 | 184,542 | Form 4 |
| 21 April 2026 | Bloom Ron A. | Director | Grant or award | +15,334 | — | 123,108 | Form 4 |
| 21 April 2026 | Camara Edilson | Director | Grant or award | +15,334 | — | 57,317 | Form 4 |
| 21 April 2026 | Cronin Jane M. | Director | Grant or award | +15,334 | — | 74,110 | Form 4 |
| 21 April 2026 | Michael Ralph S Iii | Director | Grant or award | +15,334 | — | 233,420 | Form 4 |
| 21 April 2026 | Oren Ben | Director | Grant or award | +15,334 | — | 48,068 | Form 4 |
| 21 April 2026 | Yocum Arlene M | Director | Grant or award | +15,334 | — | 136,467 | Form 4 |
| 1 April 2026 | Bloom Ron A. | Director | Grant or award | +4,837 | $8.27 | 107,774 | Form 4 |
| 1 April 2026 | Cronin Jane M. | Director | Grant or award | +4,534 | $8.27 | 58,776 | Form 4 |
| 1 April 2026 | Stoliar Gabriel | Director | Grant or award | +2,418 | $8.27 | 259,717 | Form 4 |
| 1 April 2026 | Stoliar Gabriel | Director | Shares withheld for tax | −725 | $8.27 | 258,992 | Form 4 |
| 17 February 2026 | Smith Clifford T | EVP & Chief Operating Officer | Open-market sale | −200,000 | $10.46 | 560,529 | Form 4 |
| 13 February 2026 | Camara Edilson | Director | Open-market purchase | +19,700 | $10.13 | 41,983 | Form 4 |
| 11 February 2026 | Goncalves Lourenco | Chairman, President & CEO | Open-market sale | −3,000,000 | $12.42 | 0 | Form 4 |
| 5 January 2026 | Goncalves Lourenco | Chairman, President & CEO | Shares withheld for tax | −84,229 | $13.20 | 3,015,486 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Cleveland-Cliffs page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.